Professor Michael Peter Findlay

Biography

Michael Findlay completed his undergraduate studies at the University of Otago.  He was awarded his Fellowship of the Royal Australasian College of Physicians in 1990 after training in Wellington and Sydney. His post-Fellowship research in the treatment of gastro-intestinal cancers at the Royal Marsden Hospital in London resulted in the awarding of the degree of Doctor of Medicine in 1995. After appointments at Sydney Cancer Centre and Wellington Cancer Centre between 1994 and 2002, he was appointed as the foundation Professor in Oncology at the University of Auckland. With his appointment he established Cancer Trials New Zealand, a clinical trials coordinating centre engaged in the design and conduct of clinical and translational trials in a wide range of cancer types – trials that are considered to be of particular significance to New Zealanders. Other current activities related to cancer and cancer research include: board director and deputy–chairman of the Australasian Gastro-Intestinal Trials Group and its Scientific Advisory Committee; member of the Genesis Oncology Trust Scientific Evaluation Committee, board member of the Auckland Division of the New Zealand Cancer Society; and member of the National Ethics Advisory Committee. Michael is an advocate of research-driven cancer care.

Research interests

Selected publications and creative works (Research Outputs)

  • Cebon, J. S., Gore, M., Thompson, J. F., Davis, I. D., McArthur, G. A., Walpole, E., ... MacGregor, D. (2020). Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma. Journal for immunotherapy of cancer, 8 (1).10.1136/jitc-2019-000410
    Other University of Auckland co-authors: Rod Dunbar, Margaret Brimble
  • Gurney, J. K., Sarfati, D., Lawrence, B., Jackson, C., Findlay, M., & McPherson, K. (2020). Cancer research in the New Zealand context: Challenges and advantages. JOURNAL OF CANCER POLICY, 2310.1016/j.jcpo.2019.100204
    Other University of Auckland co-authors: Ben Lawrence
  • Helsby, N. A., Duley, J., Burns, K. E., Bonnet, C., Jeong, S. H., Brenman, E., ... Findlay, M. (2020). A case-control study to assess the ability of the thymine challenge test to predict patients with severe to life threatening fluoropyrimidine-induced gastrointestinal toxicity. British journal of clinical pharmacology, 86 (1), 155-164. 10.1111/bcp.14153
    Other University of Auckland co-authors: Nuala Helsby, Katie Burns, Soo Hee Jeong
  • Henare, K. L., Parker, K., Wihongi, H., Blenkiron, C., Jansen, R., Reid, M., ... Print, C. (2019). Mapping a route to Māori engagement for clinical cancer genomics. Paper presented at New Zealand Society for Oncology Conference 2019, Wellington, New Zealand. 25 October - 26 October 2019. Related URL.
    Other University of Auckland co-authors: Kimiora Henare, Cherie Blenkiron, Papaarangi Reid, Ben Lawrence, Cristin Print
  • Burns, K. E., Allright, D., Porter, D., Findlay, M. P., & Helsby, N. A. (2019). A simple ex vivo bioassay for 5-FU transport into healthy buccal mucosal cells. Cancer chemotherapy and pharmacology, 84 (4), 739-748. 10.1007/s00280-019-03904-4
    Other University of Auckland co-authors: Nuala Helsby, Katie Burns
  • So, Y. J., Jameson, M., Newton, V., O'Donnell A, Jeffery, M., Jackson, C., ... Anderson, M. (2019). Investigating strategies to improve clinical trial opportunities for patients with cancer in New Zealand-INSIGHT. The New Zealand medical journal, 132 (1498), 10-31.
  • Henare, K. L., Parker, K. E., Wihongi, H., Blenkiron, C., Jansen, R., Reid, P., ... Print, C. G. (2019). Mapping a route to Indigenous engagement in cancer genomic research. The Lancet. Oncology, 20 (6), e327-e335. 10.1016/s1470-2045(19)30307-9
    Other University of Auckland co-authors: Kimiora Henare, Cherie Blenkiron, Papaarangi Reid, Ben Lawrence, Cristin Print
  • Gibbs, P., Heinemann, V., Sharma, N. K., Taieb, J., Ricke, J., Peeters, M., ... Strickland, A. (2018). Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies. Clinical colorectal cancer, 17 (4), e617-e629. 10.1016/j.clcc.2018.06.001

Contact details

Primary office location

M&HS BUILDING 505 - Bldg 505
Level 1, Room 102B
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand